Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for August 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
FDA Could Green-Light COVID-19 Vaccines Before Clinical Trials Completed
MONDAY, Aug. 31, 2020 (HealthDay News) — Emergency use authorization (EUA) or approval for a COVID-19 vaccine before phase 3 clinical trials are complete could be considered by the U.S. Food and Drug Administration, according to the agency’s commissioner, Stephen Hahn, M.D.
Follow-up Calls After Mohs Surgery Do Not Boost Satisfaction
MONDAY, Aug. 31, 2020 (HealthDay News) — Postoperative follow-up telephone calls (TFU) to patients after Mohs micrographic surgery (MMS) do not improve patient satisfaction, according to a research letter published online July 31 in the Journal of the American Academy of Dermatology.
Abstract/Full Text (subscription or payment may be required)
Long-Term Follow-Up Reported for BP Telemonitoring Program
MONDAY, Aug. 31, 2020 (HealthDay News) — Among adults with uncontrolled blood pressure, fewer cardiovascular events and lower costs were observed at five years with a pharmacist-led telemonitoring program, but the differences were not statistically significant compared with usual care, according to a study published online Aug. 31 in Hypertension.
Abstract/Full Text (subscription or payment may be required)
Use of Performance-Enhancing Substances Tied to Risk Behaviors
MONDAY, Aug. 31, 2020 (HealthDay News) — Use of legal performance-enhancing substances (PES) in young adults is associated with an increased likelihood of future problematic alcohol use and drinking-related risk behaviors, according to a study published online Aug. 31 in Pediatrics.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Vitamin C Positively Linked to Skeletal Muscle Mass Measures
FRIDAY, Aug. 28, 2020 (HealthDay News) — Dietary and circulating vitamin C are positively associated with measures of skeletal muscle mass in middle- and older-aged men and women, according to a study published online Aug. 27 in The Journal of Nutrition.
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Aug. 24 to 28, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Homicide, Suicide, and Overdose Leading Causes of Maternal Death 
Model Predicts Poor Outcomes Within 30 Days of a Before Medically Advised Discharge 
Fewer Than Half of Drug Overdose Survivors Go to the Hospital 
2000 to 2023 Saw Rise in Pediatric Exposure to Medications, Supplements 
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes .jpg)
Warning Symptoms, Clinical History Can Predict Sudden Cardiac Arrest 
Protocol IDs Patients Who Can Be Treated While Seated in the ED .jpg)
Once-Weekly Oral Islatravir-Lenacapavir Noninferior to Daily B/F/TAF in HIV 
